The objective is to help Konica Minolta and acquired companies in decision-making for R & D, and to accelerate the development of companion diagnostic (CDx) technologies and services.
Nikkei Biotech news release, November 28, 2018
The objective is to help Konica Minolta and acquired companies in decision-making for R & D, and to accelerate the development of companion diagnostic (CDx) technologies and services.
Nikkei Biotech news release, November 28, 2018